"..that would give us $65-70PPS." Definitely your math is right and you PE is conservative relative to other enterprise BP's. I think we can see those #'s AFTER we uplist to Nasdaq. There only a few IB's and funds that dabble in the OTCBB. IMOnly - we will see something between $10-$15 upon approval. We'll start seeing better numbers after uplist + any of the countries BLA acceptance for HIV.
Note, this is only for 2021. You don't even want to now about my 3 year out projection if some of these trials end up in PH3 and passing.